Screening and identification of the tumor‐associated antigen CK10, a novel potential liver cancer marker
Open Access
- 21 March 2017
- journal article
- research article
- Published by Wiley in FEBS Open Bio
- Vol. 7 (5) , 627-635
Abstract
Hepatocellular carcinoma (HCC) is a malignancy that is associated with high mortality rates in Asia. These tumors are highly invasive and their etiology is frequently unknown. Thus, most patients are diagnosed in the middle and late stages of the disease, and thus do not have sufficient time for therapy. Therefore, it is essential to study the early diagnosis and treatment of HCC; in this regard, the study of tumor‐associated antigens has received much attention. Here, antigens from the human primary HCC cell line, QGY‐7703, were used to immunize mice in order to prepare monoclonal antibodies. The specific antigen recognized by antibody 11C3 was purified from total protein lysates of QGY‐7703 by immunoaffinity chromatography. The validity of the candidate antigen as a new HCC‐associated marker was tested using SDS/PAGE, western blot, HPLC‐ESI‐MS/MS, and RT‐qPCR. Our results showed that the levels of CK10 in HCC‐derived cell lines were significantly higher than those in normal liver cells. Thus, we suggest that CK10 may be involved in the formation and development of HCC, and may be a therapeutically targetable tumor‐associated antigen.Keywords
Funding Information
- Open cooperation project of Henan province (142106000047)
- Innovation Scientists and Technicians Troop Construction Projects of Henan Province (164100510002)
- Program for Science & Technology Innovation Talents in Universities of Henan Province (13HASTIT023)
This publication has 35 references indexed in Scilit:
- Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesionsToxicology and Applied Pharmacology, 2010
- Using Proteomic Approach to Identify Tumor-Associated Antigens as Markers in Hepatocellular CarcinomaJournal of Proteome Research, 2008
- Principles and use of anti-CTLA4 antibody in human cancer immunotherapyCurrent Opinion in Immunology, 2006
- Histological types and significance of bronchial epithelial dysplasiaLaboratory Investigation, 2006
- Cytokeratin contents of basal cell carcinoma, epidermis overlying tumour, and associated stromal amyloidosis: An immunohistochemical studyAmyloid, 2005
- From Proteomic Analysis to Clinical SignificanceMolecular & Cellular Proteomics, 2004
- Hepatocellular carcinoma in the developing worldSeminars in Oncology, 2001
- Rare Expression of High-Molecular-Weight Cytokeratin in Adenocarcinoma of the Prostate GlandAmerican Journal of Surgical Pathology, 1999
- Cancer antigens: immune recognition of self and altered self.Journal of Experimental Medicine, 1994
- Alpha‐fetoprotein production by hepatocellular carcinoma is prognostic of poor patients survivalJournal of Surgical Oncology, 1992